研究目的
To develop a highly sensitive and specific nanoplasmonic sensor for detecting tumor suppressor microRNAs directly in patient plasma for early cancer diagnosis, leveraging a new plasmoelectronic transduction mechanism.
研究成果
The nanoplasmonic sensor demonstrates unprecedented sensitivity for microRNA detection, down to zeptomolar levels, enabled by a novel plasmoelectronic effect involving electron wavefunction delocalization. Tumor suppressor microRNAs are identified as more specific biomarkers for differentiating metastatic and non-metastatic bladder cancer than oncogenic microRNAs. This technology holds promise for non-invasive liquid biopsies and early cancer diagnostics.
研究不足
The study is limited to bladder cancer and specific microRNAs; applicability to other cancers requires further investigation. The mechanism relies on precise control of nanostructure parameters, which may be complex to standardize. The sensitivity is highly dependent on the linker length and duplex integrity, potentially limiting robustness in varied biological samples.
1:Experimental Design and Method Selection:
The study involves designing nanoplasmonic sensors using gold triangular nanoprisms (Au TNPs) functionalized with thiol-modified ssDNA and PEG. The transduction mechanism is based on the delocalization of photoexcited conduction electrons into ssDNA/microRNA duplexes, altering LSPR properties.
2:Sample Selection and Data Sources:
Bladder cancer patient plasma samples (metastatic, non-metastatic, and normal controls) were used, obtained from Indiana University medical school. Synthetic microRNAs and ssDNAs were purchased from Integrated DNA Technologies.
3:List of Experimental Equipment and Materials:
Materials include chloro(triethylphosphine) gold (I), poly(methylhydrosiloxane), trioctylamine, acetonitrile, methanol, thiol-modified ssDNAs and microRNAs, (3-mercaptopropyl)-triethoxysilane, ethanol, thiolated polyethylene glycols, RNase free water, glass coverslips, RBS 35 Detergent, PBS buffer. Equipment includes UV-visible spectrophotometer for LSPR measurements, fluorescence spectrometer for quantification, scanning electron microscope for imaging, and diamond cutter for substrate preparation.
4:Experimental Procedures and Operational Workflow:
Au TNPs were synthesized and attached to silanized glass substrates. Sensors were functionalized with mixed HS-ssDNA and HS-PEG, then incubated with microRNA solutions. LSPR extinction spectra were collected before and after hybridization to determine peak shifts. Calibration curves were developed, and microRNA concentrations in patient samples were quantified. Specificity tests involved single base-pair mismatches and fluorescence-based quantification.
5:Data Analysis Methods:
LSPR peak shifts (ΔλLSPR) were determined using Origin software for curve fitting. Limit of detection (LOD) was calculated as mean + 3σ of blank measurements. Statistical analysis used one-way ANOVA for patient sample comparisons.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容